| __timestamp | ACADIA Pharmaceuticals Inc. | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 50829000 |
| Thursday, January 1, 2015 | 90804000 | 57305000 |
| Friday, January 1, 2016 | 186456000 | 116145000 |
| Sunday, January 1, 2017 | 255062000 | 159362000 |
| Monday, January 1, 2018 | 265758000 | 206366000 |
| Tuesday, January 1, 2019 | 325638000 | 228244000 |
| Wednesday, January 1, 2020 | 388661000 | 293355000 |
| Friday, January 1, 2021 | 396028000 | 401715000 |
| Saturday, January 1, 2022 | 369090000 | 459856000 |
| Sunday, January 1, 2023 | 402466000 | 542705000 |
| Monday, January 1, 2024 | 492128000 |
Cracking the code
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Exelixis, Inc. and ACADIA Pharmaceuticals Inc. have demonstrated contrasting strategies in optimizing these costs. From 2014 to 2023, Exelixis, Inc. has shown a remarkable 967% increase in SG&A expenses, peaking in 2023. Meanwhile, ACADIA Pharmaceuticals Inc. experienced a 1,129% rise, with a notable surge in 2023.
Exelixis, Inc. maintained a more consistent growth trajectory, with expenses increasing steadily each year. In contrast, ACADIA Pharmaceuticals Inc. saw more volatility, with significant jumps in 2016 and 2020. This data highlights the strategic differences in cost management between the two companies, offering valuable insights for investors and industry analysts alike.
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and Opthea Limited
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Selling, General, and Administrative Costs: Exelixis, Inc. vs BioCryst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends